EULAR webinar with Quality of Care

Welcome to EULAR webinar with Quality of Care (QoC)

The workup and management of patients with Giant Cell Arteritis

In this upcoming webinar on vasculitis, Christina Ponte, Christian Dejaco, and Bernhard Hellmich will delve into crucial aspects based on the recently synthesized evidence. Christina Ponte will elucidate the clinical evaluation of individuals suspected of giant cell arteritis, encompassing differential diagnosis and current classification criteria. Furthermore, Christian Dejaco will shed light on the essential imaging modalities required for patients with suspected giant cell arteritis. Bernhard Hellmich will outline the available management options. By integrating the expertise and research findings from the publications on treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatic, as well as EULAR recommendations for imaging in large vessel vasculitis, this webinar aims to provide a comprehensive understanding of the pathophysiology, diagnosis, imaging, management, and collaborative strategies in the care of patients with vasculitis syndromes.

Tuesday, 6 May 2025, 17:00 -18:00 CEST

Title: The 2023 Update of EULAR Recommendations on the non-pharmacological management of hip/knee OA: What’s in it for us?

* Pay attention to the time zone differences 

Speakers:

Tuva Moseng, MSc, Dr.
Postdoctoral researcher, PT REMEDY - Center for treatment of Rheumatic and Musculoskeletal Diseases Diakonhjemmet Hospital, Oslo, Norway

Simone Battista, Dr. 
Research Fellow / School of Health & Society, University of Salford, Manchester, United Kingdom

Chairs: 

Bente Appel Esbensen, Prof. 

Senior Researcher, RN, MSciN, PhD, Rigshospitalet, Denmark

George S. Metsios, Prof.

Senior Researcher, University of Wolverhampton, United Kingdom

Learning objectives

• Understand the importance of an individualized, multicomponent management plan for hip and knee osteoarthritis (OA)
• Learn why combining different treatment options is essential for effective OA management.
• Explore core non-pharmacological approaches for managing OA